Article
Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies
21 Sept 2024
Abstract excerpt
Background: Breast cancer therapy has been facing remarkable changes. Classic treatments are now combined with other therapies to improve efficacy and surpass resistance. Indeed, the emergence of resistance demands the development of novel therapeutic approaches. Due to key estrogen signaling, estrogen receptor-positive (ER+) breast cancer treatment has always been focused on aromatase inhibition and ER...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
